Corporate markets wait hungrily for paper as M&A boom begins
The upswing in big ticket mergers and acquisitions is finally arriving. Latest to clinch a deal is Bayer, which has outbid the pharmaceutical industry’s finest to win Merck’s consumer healthcare division with a $14.2bn bid.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts